Charles B. Smith

5.7k total citations · 1 hit paper
98 papers, 4.3k citations indexed

About

Charles B. Smith is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Epidemiology. According to data from OpenAlex, Charles B. Smith has authored 98 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 29 papers in Molecular Biology and 19 papers in Epidemiology. Recurrent topics in Charles B. Smith's work include Receptor Mechanisms and Signaling (21 papers), Neuropeptides and Animal Physiology (18 papers) and Neuroscience and Neuropharmacology Research (16 papers). Charles B. Smith is often cited by papers focused on Receptor Mechanisms and Signaling (21 papers), Neuropeptides and Animal Physiology (18 papers) and Neuroscience and Neuropharmacology Research (16 papers). Charles B. Smith collaborates with scholars based in United States, Japan and United Kingdom. Charles B. Smith's co-authors include Richard A. Garibaldi, John P. Burke, Robert M. Chanock, Peggie J. Hollingsworth, Fulton T. Crews, Jesús A. García‐Sevilla, Joseph A. Bellanti, William T. Friedewald, Gregory A. Jicha and Erin L. Abner and has published in prestigious journals such as Science, New England Journal of Medicine and Annals of Internal Medicine.

In The Last Decade

Charles B. Smith

98 papers receiving 3.9k citations

Hit Papers

Factors Predisposing to Bacteriuria during Indwelling Ure... 1974 2026 1991 2008 1974 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles B. Smith United States 34 1.1k 1.0k 992 592 394 98 4.3k
Eugène Bosmans Belgium 55 909 0.8× 507 0.5× 1.2k 1.2× 744 1.3× 579 1.5× 104 10.1k
Thomas J. Walsh United States 43 1.1k 1.0× 953 0.9× 1.4k 1.4× 209 0.4× 484 1.2× 193 6.3k
P Franchimont Belgium 48 887 0.8× 519 0.5× 2.1k 2.1× 543 0.9× 395 1.0× 358 9.1k
Masatoshi Tanaka Japan 30 497 0.4× 434 0.4× 727 0.7× 471 0.8× 346 0.9× 168 3.2k
Francisco Arnalich Spain 41 1.0k 0.9× 523 0.5× 1.2k 1.2× 814 1.4× 499 1.3× 210 6.2k
Marlies Leenaars Netherlands 21 397 0.4× 254 0.2× 950 1.0× 470 0.8× 316 0.8× 33 4.9k
Claude Bohuon France 40 3.7k 3.3× 636 0.6× 1.2k 1.2× 286 0.5× 135 0.3× 173 7.4k
Terry M. Phillips United States 42 692 0.6× 655 0.6× 1.3k 1.3× 803 1.4× 495 1.3× 144 7.1k
Michale E. Keeling United States 17 569 0.5× 415 0.4× 1.1k 1.1× 344 0.6× 204 0.5× 37 4.8k
B. Larsson Sweden 35 343 0.3× 378 0.4× 546 0.6× 574 1.0× 75 0.2× 118 3.2k

Countries citing papers authored by Charles B. Smith

Since Specialization
Citations

This map shows the geographic impact of Charles B. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles B. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles B. Smith more than expected).

Fields of papers citing papers by Charles B. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles B. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles B. Smith. The network helps show where Charles B. Smith may publish in the future.

Co-authorship network of co-authors of Charles B. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Charles B. Smith. A scholar is included among the top collaborators of Charles B. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles B. Smith. Charles B. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Charles B., Margaret P. Battin, Leslie P. Francis, & Jay A. Jacobson. (2007). SHOULD RAPID TESTS FOR HIV INFECTION NOW BE MANDATORY DURING PREGNANCY? GLOBAL DIFFERENCES IN SCARCITY AND A DILEMMA OF TECHNOLOGICAL ADVANCE. Developing World Bioethics. 7(2). 86–103. 1 indexed citations
2.
Smith, Charles B., Margaret P. Battin, Jay A. Jacobson, et al.. (2004). Are there Characteristics of Infectious Diseases that Raise Special Ethical Issues?1. Developing World Bioethics. 4(1). 1–16. 24 indexed citations
4.
Smith, Charles B., Ronald L. Goldman, Donald C. Martin, et al.. (1996). Overutilization of Acute-Care Beds in Veterans Affairs Hospitals. Medical Care. 34(1). 85–96. 34 indexed citations
5.
Yoshioka, Mitsuhiro, et al.. (1995). Changes in the regulation of 5-hydroxytryptamine release by α2-adrenoceptors in the rat hippocampus after long-term desipramine treatment. European Journal of Pharmacology. 294(2-3). 565–570. 36 indexed citations
6.
Matsumoto, Machiko, Mitsuhiro Yoshioka, Hiroko Togashi, et al.. (1994). Mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis. Brain Research. 636(1). 1–8. 31 indexed citations
7.
Yoshioka, Mitsuhiro, et al.. (1992). Effect of clonidine on the release of serotonin from the rat hippocampus as measured by microdialysis. Neuroscience Letters. 139(1). 57–60. 17 indexed citations
8.
Yoshioka, Mitsuhiro, Machiko Matsumoto, Hiroko Togashi, Charles B. Smith, & Hideya Saito. (1992). α2-Adrenoceptor modulation of 5-HT biosynthesis in the rat brain. Neuroscience Letters. 139(1). 53–56. 28 indexed citations
9.
Heyl, Deborah, John R. Omnaas, Katarzyna Sobczyk‐Kojiro, et al.. (1991). Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide‐containing opioid tetrapeptide. International journal of peptide & protein research. 37(3). 224–229. 7 indexed citations
11.
Lee, Myung A., Oliver G. Cameron, George N.M. Gurguis, et al.. (1990). Alpha2-adrenoceptor status in obsessive-compulsive disorder. Biological Psychiatry. 27(10). 1083–1093. 29 indexed citations
12.
Hollingsworth, Peggie J. & Charles B. Smith. (1989). Effects of muscarinic receptor agonists and antagonists on α2-adrenoceptors in rat brain. European Journal of Pharmacology. 168(2). 159–167. 4 indexed citations
14.
Grunhaus, Leon, et al.. (1989). Intravenous Yohimbine Selective Enhancer of Norepinephrine and Cortisol Secretion and Systolic Blood Pressure in Humans. Clinical Neuropharmacology. 12(2). 106–114. 23 indexed citations
15.
Mosberg, Henry I., John R. Omnaas, Fedor Medzihradsky, & Charles B. Smith. (1988). Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: Development of a ligard with high delta opioid receptor selectivity and affinity. Life Sciences. 43(12). 1013–1020. 55 indexed citations
16.
Moises, Hylan C. & Charles B. Smith. (1987). Changes in cortical β-adrenergic receptor density and neuronal sensitivity to norepinephrine accompany morphine dependence and withdrawal. Brain Research. 400(1). 110–126. 19 indexed citations
17.
Moises, Hylan C. & Charles B. Smith. (1984). Changes occur in central adrenoreceptor function following long-term morphine treatment and during morphine withdrawal. Neuropeptides. 5(1-3). 29–32. 7 indexed citations
18.
Weiss, Robert & Charles B. Smith. (1983). Altered platelet alpha2-adrenoceptors in patients with angina pectoris. Journal of the American College of Cardiology. 2(4). 631–637. 13 indexed citations
19.
Smith, Charles B.. (1966). THE ROLE OF MONOAMINE OXIDASE IN THE INTRANEURONAL METABOLISM OF NOREPINEPHRINE RELEASED BY INDIRECTLY-ACTING SYMPATHOMIMETIC AMINES OR BY ADRENERGIC NERVE STIMULATION. Journal of Pharmacology and Experimental Therapeutics. 151(2). 207–220. 37 indexed citations
20.
Smith, Charles B.. (1965). EFFECTS OF d-AMPHETAMINE UPON BRAIN AMINE CONTENT AND LOCOMOTOR ACTIVITY OF MICE. Journal of Pharmacology and Experimental Therapeutics. 147(1). 96–102. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026